Inventory increased 40.5%
Inventory changed +40.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$75.4M→$105.9M4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →ALNY financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Working capital / assets moved 1127 bp lower
Working capital / assets changed -1127 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
49.41%→38.15%4 prior comparisons
Operating margin moved 575 bp lower
Operating margin changed -575 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
29.46%→23.72%2 prior comparisons
Working capital increased 27.2%
Working capital changed +27.2% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$2.4B→$3.0B4 prior comparisons
Gross margin moved 902 bp lower
Gross margin changed -902 basis points from the comparable as-filed period.
84.21%→75.19%2 prior comparisons
Cost of revenue increased 83.4%
Cost of revenue changed +83.4% from the comparable as-filed period.
$197.2M→$361.8M2 prior comparisons
SBC / revenue moved 324 bp lower
SBC / revenue changed -324 basis points from the comparable as-filed period.
8.66%→5.43%2 prior comparisons
Capex / revenue moved 382 bp higher
Capex / revenue changed +382 basis points from the comparable as-filed period.
0.97%→4.79%2 prior comparisons
Revenue increased 16.7%
Revenue changed +16.7% from the comparable as-filed period.
$1.2B→$1.5B2 prior comparisons
Operating margin moved 2002 bp higher
Operating margin changed +2002 basis points from the comparable as-filed period.
-2.09%→17.93%2 prior comparisons
Revenue increased 66.9%
Revenue changed +66.9% from the comparable as-filed period.
$773.7M→$1.3B2 prior comparisons
Gross margin moved 475 bp lower
Gross margin changed -475 basis points from the comparable as-filed period.
81.64%→76.90%2 prior comparisons
Cash & equivalents increased 53.4%
Cash & equivalents changed +53.4% from the comparable as-filed period.
$1.1B→$1.7B2 prior comparisons
Cost of revenue increased 110.0%
Cost of revenue changed +110.0% from the comparable as-filed period.
$142.0M→$298.3M2 prior comparisons
Trade receivables increased 60.9%
Trade receivables changed +60.9% from the comparable as-filed period.
$567.1M→$912.7M3 prior comparisons
Working capital increased 32.6%
Working capital changed +32.6% from the comparable as-filed period.
$2.3B→$3.1B3 prior comparisons
Stockholders' equity increased 440.4%
Stockholders' equity changed +440.4% from the comparable as-filed period.
$250.6M→$1.4B2 prior comparisons
Research & development increased 27.7%
Research & development changed +27.7% from the comparable as-filed period.
$323.6M→$413.1M2 prior comparisons
SBC / revenue moved 772 bp lower
SBC / revenue changed -772 basis points from the comparable as-filed period.
14.43%→6.71%2 prior comparisons
Current assets increased 26.8%
Current assets changed +26.8% from the comparable as-filed period.
$3.6B→$4.6B3 prior comparisons
Operating income changed across a sign change
Operating income changed +1528.7% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-$16.2M→$231.4M2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.